[1]
R. S. Viswas, “Inhalable Mucoadhesive Nanoparticles of Favipiravir as Drug Delivery Systems to the Lungs in Dry Powder Formulations: Inhalable Mucoadhesive Nanoparticles of Favipiravir ”, P, vol. 37, no. 1, Mar. 2025.